No objection letter received from U.K. for Tectin clinical trial
In: Science Letter, 2005-07-05, S. 344
Zeitungsartikel
Zugriff:
WEX Pharmaceuticals Inc. announced that it has received a no objection letter (NOL) from Health Canada to amend the phase IIb/III clinical trial protocol for Tectin in moderate to severe [...]
Titel: |
No objection letter received from U.K. for Tectin clinical trial
|
---|---|
Zeitschrift: | Science Letter, 2005-07-05, S. 344 |
Veröffentlichung: | 2005 |
Medientyp: | Zeitungsartikel |
ISSN: | 1538-9111 (print) |
Schlagwort: |
|
Sonstiges: |
|